Used in research as a selective c-Met kinase inhibitor, showing potential in suppressing tumor growth and cancer cell proliferation. Demonstrates antitumor activity in preclinical models, particularly in cancers driven by c-Met signaling pathway dysregulation. Investigated for its ability to inhibit cell migration and invasion, making it a candidate for studying metastatic disease progression. Also employed in pharmacological studies to understand kinase inhibition mechanisms and optimize targeted cancer therapies.